Grant Yonehiro - 23 Jul 2024 Form 4 Insider Report for Bolt Biotherapeutics, Inc. (BOLT)

Role
Chief Operating Officer
Signature
/s/ William P. Quinn, Attorney-in-Fact
Issuer symbol
BOLT
Transactions as of
23 Jul 2024
Transactions value $
$0
Form type
4
Filing time
24 Jul 2024, 17:26:43 UTC
Previous filing
06 Mar 2024
Next filing
05 May 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BOLT Stock Option (Right to Buy) Award $0 +155K $0.00 155K 23 Jul 2024 Common Stock 155K $0.73 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 For so long as the Reporting Person continuously provides services to the Issuer this option will vest with respect to the shares as follows: 1/36th of the Shares will vest upon the Reporting Person completing each month of continuous service following July 15, 2024.